Table 1.
Artery | Technique | SS-FMD | RH-FMD | Reference | |
---|---|---|---|---|---|
Intervention | Arrows versus preintervention | ||||
Prior antegrade shear stress | Brachial | Rhythmic handgrip | ↑ | 1 | |
l-NMMA and EDHF receptor inhibition | Radial | Hand heating | ↓ | 5, 8 | |
Angiotensin converting enzyme inhibitors in congestive heart failure | Radial | Hand heating | ↑ | 45 | |
l-NMMA and aspirin | Radial | Hand heating | ↔ | 60 | |
Endothelin type B receptor inhibition | Radial | Hand heating | ↓ | 6 | |
Anemia correction in end-stage renal disease | Brachial | Forearm heating | ↑ | 94 | |
Antioxidant | Brachial | Progressive handgrip | ↓ | 72 | |
Antioxidant or exercise training in the elderly | Brachial | Progressive handgrip | ↑ | 20 | |
Acute and chronic folic acid ingestion in the elderly | Brachial | Progressive handgrip | ↑ | 73 | |
l-NMMA | Brachial | Progressive handgrip | ↓ | 100 | |
l-NMMA in the elderly | Brachial | Progressive handgrip | ↓ | 93 | |
Ascorbic acid and l-NMMA in the elderly | Brachial | Progressive handgrip | ↔ | 92 | |
High-fat meal | Brachial | Rhythmic handgrip | ↔ | ↓ | 62 |
Altered contraction duty cycles | Brachial | Rhythmic handgrip | ↔ | 49 | |
Cold pressor test | Brachial | Rhythmic handgrip | ↔ | 83 | |
Acute mental stress | Brachial | Rhythmic handgrip | ↔ | ↓ | 84 |
Acute mental stress and cold pressor test | Brachial | Rhythmic handgrip | ↑ | 85 | |
Cross-sectional | Arrows versus healthy controls | ||||
Uncomplicated type I diabetes | Radial | Hand heating | ↓ | ↔ | 3 |
Hypertension | Radial | Hand heating | ↓ | ↓ | 7 |
Autosomal dominant polycystic kidney disease | Radial | Hand heating | ↓ | ↔ | 56 |
End-stage renal disease | Brachial | Forearm heating | ↓ | 94 | |
Hypercholesterolemia | Brachial | Distal acetylcholine infusion | ↔ | ↓ | 60 |
Young smokers | Brachial | Rhythmic handgrip | ↓ | ↔ | 25 |
Obese young adults | Brachial | Rhythmic handgrip | ↓ | ↔ | 81 |
Systemic sclerosis | Brachial | Progressive handgrip | ↓ | 57 |
SS-FMD, sustained shear stress flow-mediated dilation; RH-FMD, reactive hyperemia flow-mediated dilation; l-NMMA, NG-monomethyl-l-arginine.